MedPath

Multiple Electrolytes pH 7.4

Multiple Electrolytes Injection, Type 1, USP, pH 7.4 in FREEFLEX Plastic Container

Approved
Approval ID

84221110-b3f1-42f4-800c-ad1d3b330e9e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 10, 2022

Manufacturers
FDA

Fresenius Kabi USA, LLC

DUNS: 013547657

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65219-389
Application NumberANDA215371
Product Classification
M
Marketing Category
C73584
G
Generic Name
sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJune 18, 2021
FDA Product Classification

INGREDIENTS (6)

SODIUM CHLORIDEActive
Quantity: 526 mg in 100 mL
Code: 451W47IQ8X
Classification: ACTIB
SODIUM GLUCONATEActive
Quantity: 502 mg in 100 mL
Code: R6Q3791S76
Classification: ACTIB
SODIUM ACETATEActive
Quantity: 368 mg in 100 mL
Code: 4550K0SC9B
Classification: ACTIB
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
POTASSIUM CHLORIDEActive
Quantity: 37 mg in 100 mL
Code: 660YQ98I10
Classification: ACTIB
MAGNESIUM CHLORIDEActive
Quantity: 30 mg in 100 mL
Code: 02F3473H9O
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Multiple Electrolytes pH 7.4 - FDA Drug Approval Details